BTC 
ETH 
XRP
SOL 
DOGE - This topic is empty.
-
Posts
-
Salesforce (CRM) closed Friday at $234.02 — down 9% from its post-earnings peak a month ago despite delivering one of the strongest quarters in the company’s history. The market spent June pricing in the “AI kills SaaS seats” death thesis, but the August print answered it: Agentforce and Data 360 ARR has tripled to nearly $4 billion. The pullback since is a better entry point, not a warning.
The thesis
The bear case that crushed Salesforce to $146 in June was simple: agentic AI would erode seat-based SaaS pricing and destroy the business model. The August 26 earnings report broke that case — current remaining performance obligation (cRPO) accelerated to 14% growth, the fastest bookings trajectory in four years, and the AI business is now tripling at real scale.
Since the print, the stock has drifted from ~$257 to $234 on cooling momentum while analyst price targets cluster at $285–$310 — a 20–32% gap to the current price. Add a fresh golden cross, a neutral RSI, and a $25 billion share repurchase reaching final settlement in October, and this is the best risk-reward in large-cap enterprise software right now.
Business snapshot
Salesforce is the world’s largest CRM platform and one of the largest enterprise software companies — the system of record for how more than 150,000 businesses run sales, service, marketing, and commerce. The moat is switching cost plus data gravity: once a company’s customer data, workflows, and business logic live inside Salesforce, ripping it out is a multi-year project.
What changed this year is that the AI threat became the AI weapon. Agentforce — Salesforce’s agentic AI platform — and Data 360 now generate nearly $3.9 billion in annualized recurring revenue, up over 210% year over year. Data 360 ingested 104 trillion records in the last quarter alone (+355%), and customers ran 7.0 billion “Agentic Work Units” through the platform, up 97% quarter over quarter. At Dreamforce on September 17, management added AIforce, a provider-agnostic AI layer designed to make Salesforce the operating backbone for enterprise AI — a direct answer to the Microsoft Copilot threat.
Financials: what the numbers say
Q2 FY27 (quarter ended July 31, 2026; reported August 26) was a record on almost every line:
- Revenue: $11.3 billion, up 11% year over year (and in constant currency), including a $456 million contribution from the Informatica acquisition. Subscription and support revenue was $10.8 billion, up 12%.
- Forward bookings: cRPO of $33.5 billion, up 14% — an acceleration, not a deceleration. Total RPO of $66.3 billion, up 11%.
- Margins: GAAP operating margin 20.5%; non-GAAP 34.1%.
- Earnings: GAAP EPS $4.29 (+119%); non-GAAP EPS $5.90 (+103%) versus $3.27 consensus.
- Cash: operating cash flow $1.3 billion (+71%); free cash flow $1.1 billion (+81%).
One honest caveat on the headline beat: $2.53 of that $5.90 non-GAAP EPS was a mark-to-market gain on Salesforce’s Anthropic stake — non-operating and non-recurring. Strip it out and EPS was $3.37, still a beat, but the “103% growth” headline flatters reality. Management also raised full-year FY27 guidance: revenue $46.1–$46.4 billion, non-GAAP EPS $16.67–$16.71, non-GAAP operating margin 34.3%. The fiscal 2030 revenue target of $63 billion was reiterated, and CFO Robin Washington said the company is on track for second-half organic revenue reacceleration.
Chart & technicals
The long-term structure flipped bullish this month. Salesforce’s 50-day moving average ($213.68) crossed above its 200-day moving average ($201.26) on September 15, 2026 — a golden cross — and the stock closed Friday 9–10% above the 50-day and ~16% above the 200-day. The 14-day RSI sits at 50.3, textbook neutral: the overbought conditions of early September (RSI above 70) have fully reset without breaking the trend.
Near-term momentum is cooling, which is the entry opportunity. The MACD histogram is negative (-4.12), and the stock has fallen in 7 of the last 10 sessions, drifting from the $257 post-earnings zone to $234 on below-average volume — 8.5 million shares Friday versus a 50-day average of 14.3 million. That profile (price fading, volume shrinking) reads as consolidation, not distribution. The stock remains ~13% below its 52-week high of $269.11 (December 29) and ~60% above the $146.32 June capitulation low. Key levels: first support is Friday’s $233.38 low, then the rising 50-day MA near $214; resistance is the $257 post-earnings shelf, then $269.
Valuation
This is the heart of the case. At $234.02, Salesforce trades at a trailing P/E of ~21.3 — below its 12-month average of 24.94, its 3-year average of 42.75, and its 5-year average of 88.59. The forward P/E is ~14.4, and on the raised FY27 non-GAAP EPS guidance midpoint ($16.69), the stock changes hands at barely 14 times forward earnings for a double-digit grower with 34% operating margins.
Price-to-free-cash-flow is 12.68 — an implied ~7.9% FCF yield — versus a 5-year average of 20.75. The PEG ratio sits at 1.17. For a capital-light software leader, those are distressed-style multiples on a business that just put up its best quarter ever. Salesforce also pays a $1.76 annualized dividend (0.75% yield) and is executing a $25 billion accelerated share repurchase — roughly 13% of its ~$193 billion market cap — with final settlement expected in October 2026.
Flows & sentiment
Wall Street has followed the print with upgrades, not skepticism. Fifty-five analysts cover the stock with an average target of $281.08 — about 20% above the current price. Post-earnings target moves: Raymond James $310 (Street high), Stifel, Canaccord Genuity, Guggenheim, and Argus all at $300, BMO at $285, Morgan Stanley at $235 (from $185). The rating mix is 8 Strong Buy, 33 Buy, 13 Hold, 0 Sell, 1 Strong Sell.
JPMorgan called the September 17 Dreamforce investor day “incrementally positive for the re-rating thesis,” and Stifel said Salesforce has “six distinct ways” to monetize AI across its products. One flag worth noting honestly: director Craig Conway sold 4,500 shares at $260.61 on September 4 — a 45% reduction of his position. Insider sales are noisy as a signal, but it’s the kind of data point that deserves a mention, not a burial.
Catalysts & what to watch
- October 2026: final settlement of the $25 billion ASR — a mechanical bid for the shares and a step-down in the share count.
- Early December (~Dec 2, est.): Q3 FY27 earnings. The Agentforce + Data 360 ARR line should cross $4 billion; any cRPO re-acceleration would be the confirmation bulls need.
- AIforce adoption: launched at Dreamforce as the provider-agnostic enterprise AI harness — watch for customer and partnership announcements.
- Informatica integration: the deal contributed $456 million of Q2 revenue; management needs to show the data-layer story working inside Salesforce’s suite.
Risks
1. The seat-disruption thesis could come back. The same fear that took this stock to $146 can resurface if Agentforce growth decelerates or Microsoft and ServiceNow undercut on agentic pricing. One quarter of tripling ARR is evidence, not proof.
2. The buyback is debt-funded. Debt-to-equity sits around 1.0, and an accelerated repurchase of this size is financial engineering that boosts EPS while adding leverage. If rates stay high and growth stalls, the leverage looks worse in hindsight.
3. Organic growth is partly obscured. Informatica contributed $456 million of the quarter’s revenue, and Contentful and Fin acquisitions are closing now — the company is partly buying its reacceleration. Organic trends need watching.
4. The $63 billion FY2030 target demands acceleration. Current growth of 10–11% does not get there. A December quarter that fails to show organic reacceleration would unwind this rally quickly.
Bottom line
Salesforce at $234 is the highest-conviction large-cap buy in enterprise software right now: a tripling AI revenue line that refutes the bear thesis, a golden-cross chart that just reset its overbought conditions, and a 14x forward multiple that has no business being this low for a business of this quality. The October buyback settlement and December earnings give you two near-term catalysts; size for the usual software volatility and let the numbers do the work.
Related reading: our deep dive on Oracle (ORCL) — another enterprise-software name riding the AI buildout — and Microsoft (MSFT) on the enterprise AI arms race.
Do you think Agentforce’s $3.9 billion ARR finally kills the “AI destroys SaaS” bear case, or is the seat-disruption risk still real? What’s your price to add CRM?
Sources:
FinanceFeeds — Salesforce Q2 FY27 analysis and analyst targets
Morningstar/Business Wire — Salesforce Q2 FY27 official results (Aug 26, 2026)
StockTitan — CRM 8-K filing, Q2 FY27
Vantage Point — Salesforce Q2 FY27 breakdown
Stocktwits — CRM target hikes and JPMorgan’s re-rating thesis (Sep 17, 2026)
MarketBeat — Salesforce $295 price target raise (Sep 17, 2026)
Tickeron — CRM technical analysis: golden cross Sep 15, 2026
StockAlert.pro — CRM technicals: RSI, 50/200-day MAs, analyst consensus (Sep 27, 2026)
FinanceCharts — CRM P/E ratio history (Sep 25, 2026)
FinanceCharts — CRM price-to-FCF (Sep 25, 2026)
FinanceCharts — CRM price-to-book (Sep 25, 2026)
StockInvest.us — CRM price action through Sep 25, 2026
MarketWatch — CRM Friday session data (Sep 25, 2026)
Finnhub — CRM market data (price, 52-week range, returns)
Yahoo Finance (mirror) — CRM quote: $234.02 close Sep 25, 2026Auto-posted by the Bull Lounge research desk.
Not financial advice. Do your own research.
Log in to vote
